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1. Introduction 
Aculeacin A is the main component of a series of 
antibiotics produced by Aspergillus aculeatus [l] and 
papulacandin B is produced by Papulanb sphaero- 
sperma [2]. These compounds inhibit the growth of 
several yeasts but have little or no activity against 
bacteria or protozoa [ 1,2]. 
Aculeacin A and papulacandin B do not cause 
membrane damage and ion leakage [3,4], as in the 
case of polyene antibiotics [5], but interfere with 
cell-wall synthesis in yeast. Glucose incorporation 
into the alkali-insoluble glucan fraction of the cell 
wall of Saccharomyces cerevisiae is selectively inhib- 
ited by those antibiotics [4]. Since glucan is the main 
structural component of yeast cell wall [6], the 
weakening of the wall would be the cause of the lysis 
of the cells by osmotic pressure. The possibility of 
measuring p-(1,3) glucan-synthase ‘invitro’ in the 
fungus Geotrichum lactis has allowed us to demon- 
strate that papulacandin B and aculeacin A are indeed 
inhibitors of the synthase. We show that the inhibi- 
tion is specific and occurs not only ‘in vitro’ but also 
‘in vivo’ since the addition of the antibiotics to a cul- 
ture leads to cell-free extracts with a partially inac- 
tive synthase. Some characteristics of the inhibition 
are described. 
2. Materials and methods 
Papulacandin B and aculeacin A were generous 
gifts of Dr K. Scheibli (Ciba-Geigy, Basel) and Dr K. 
* To whom reprint requests should be addressed 
Mizuno (Toy0 Jozo, Tokyo), respectively. UDP-[U- 
14C]glucose (240 mCi/mmol, UDP-N-acetyl [U-“Cl- 
glucosamine (346 mCi/mmol) and GDP- [ U-14C] man- 
nose (179 mCi/mmol) were purchased from the 
Radiochemical Centre. UDP-glucose, UDP-N-acetyl- 
glucosamine, GDP-mannose and GTP were from Sigma. 
2.1. Organism and growth conditions 
Geotrichum lactis CECT 1102, whose perfect state 
has been described as Endomyces geotrichum [7] was 
the organism used. It was grown at 30°C in an incuba- 
tor shaker in YED medium (1% glucose and 1% yeast 
extract). 
2.2. Enzyme preparation 
Cell-free extracts were obtained by mechanical 
breakage using a Braun homogenizer and glass beads. 
The mixture contained 7 g material (wet wt), 21 ml 
1 mM EDTA (pH 7), 14 g glass beads, and was homog- 
enized for 45 s, twice, under dry ice refrigeration. 
The extracts were diluted with 10 ml 1 mM EDTA 
and centrifuged at 750 X g for 5 min to remove the 
cell walls. The resulting supernatants were centrifuged 
at 48 000 X g for 30 mm, and the pellets washed once 
with 25 ml 50 mM Tris-HCl (pH 7.5) containing 
1 mM EDTA and 1 mM mercaptoethanol. The final 
pellets were resuspended in the same buffered solu- 
tion containing 33% glycerol. All operations were 
done at 0-4”C. Chitin and mannan-synthases were 
measured in extracts prepared as for glucan-synthase, 
except hat the solutions used for washing and final 
resuspension were 2.5 mM Tris-HCl (pH 7.5) contain- 
ing 5 mM MgS04 and 25 mM imidazole-HCl (pH 6.5) 
containing 5mM MnC12, respectively. 
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2.3. Assays 
The standard incubation mixture for glucan-syn- 
thase was as in [8] except hat it always contained 
UDP-[14C]glucose (1.5 X lo5 cpm/nmol), 80 PM 
GTP, 2.5 mM EDTA and -150 pg enzyme protein. 
Incubation was for 40 min at 30°C. Under these con- 
ditions the rate of the reaction was linear. The radio- 
activity was determined with a Beckman LS-8100 
scintillation spectrometer. 
Chitin and mannan-synthase activities were assayed 
as in [9,10]. Protein was measured according to [I 11. 
One unit of enzyme is defined as the amount hat 
catalyzes the incorporation of 1 ~01 glucose/mm, 
into glucan, at 30°C. 
3. Results 
3.1. Inhibition of glucan-synthase 
Cell-free extracts from G. lactis were incubated 
under standard assay conditions in the presence and 
absence of papulacandin B and aculeacin A. Methanol 
was added to the controls in a similar amount o that 
resulting from addition of the antibiotics. Under the 
conditions of the experiment ( able 1) 70% of the 
glucan-synthase activity resulted inhibited by papula- 
candin B and 65% by aculeacin A. Glucansynthase 
activity from stationary-phase extracts, however, is 
not inhibited by the antibiotics. The degradation by 
p-(1,3) glucanases and its resistence to periodate oxi- 
dation (not shown) proved that the reaction product 
was in all cases a linear &(I ,3) glucan. 
These antibiotics not only inhibit glucan-synthase 
‘in vitro’ but when added to the growth medium lead 
to cell-free extracts with a partially inactive synthase. 
In a typical experiment, cultures of G. luctis (lml/mg 
dry wt) were supplemented with 6 pg papulacandin 
B/ml or 18 pg aculeacin A/ml and after 90 min, the 
mycelium was harvested and cell-free xtracts prepared. 
A substantial inhibition of glucan-synthase, in com- 
parison with a control, was observed (table 1). The 
growth of G. la&s under these conditions, as well as 
RNA and protein synthesis, were not altered. 
3.2. Specificity of the inhibition 
The main polysaccharide components of G. luctis 
cell wall are galactomannan, glucan and chitin [ 12, 
131. Under conditions where glucan-synthase i  inhib- 
ited (using an excess of antibiotics) both chitin and 
mannan-synthases are unaffected or slightly activated 
(table 1). These synthases appear to be localized on 
the plasma membrane inS. cerevisiae [8,14,15] and 
in other fungi, so it seems reasonable to conclude that 
glucan-synthase i  specifically inhibited by papulacan- 
din B and aculeacin A. 
The lytic effect triggered by the antibiotics ‘in vivo’ 
does not seem to be caused primarily by the activa- 
tion of endogenous fl-glucanases because the p-(1,3) 
glucanase activity, as measured in cell-free extracts, 
was unaffected by the presence of the antibiotics 
(not shown). Furthermore, experiments with Schizo- 
saccharomyces pombe have shown that p-( 1,3) glu- 
canase activity from cultures treated with papula- 
candin B is similar to that from untreated cultures. 
Table 1 
Effect of papulacandin B and aculeacin A on several cell wall synthases from G. luctis (milliunits/mg 
protein) 
In vitroa In vivob 
Control PapuIacandin B Aculeacin A Control Papulacandin B Aculeacin A 
Glucan- 
synthase 3.14 0.98 1.10 2.74 0.52 1.64 
Chit& 
synthase 13.30 13.75. 14.70 12.70 13.55 14.55 
MarUWl- 
synthase 0.48 0.57 0.56 0.48 0.54 0.57 
a Papulacandin B, 26 fig/ml, and 66 Hg aculeacin A/ml, (fmaI concentrations in the assays) 
b G. luctis cultures (1 ml/mg dry wt) were treated with papulacandin B (6 ~rg/ntl) or aculeacin A 
(18 @g/ml). After 90 min the mycelium was harvested and the synthase activities measured in the 
corresponding particulate fraction 
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3.3. Characteristics of the inhibition 
Fig.1 A represents Lineweaver-Burk plots of the 
synthase in the presence of papulacandln B. As it is 
apparent from the graph, both maximal velocity and 
Km are modified by the addition of the antibiotic. 
This is a situation of mixed-type inhibition [ 161 in 
which the affinity for the substrate isincreased by 
the addition of the inhibitor. The kinetics for aculeacin 
A inhibition is quite similar (fig.1 B). 
Another characteristic of the inhibition caused by 
these antibiotics is its incompleteness. Addition of 
increasing amounts of papulacandin B and aculeacin 
A, respectively, did not result in a complete inhibi- 
tion of the activity. The concentrations for 50% inhi- 
bition were 1.2 PM for papulacandin B and 60 PM 
for aculeacin A. The inhibition is independent of the 
time of incubation (not shown). 
I A 
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Fig. 1. Lineweaver-Burk plots of the p-(1,3) glucan-synthase 
activity at several concentrations of: (A) papulacandin B ((0) 
control. (m) 1.3 pg/ml, (A) 2.6 pg/ml, (v) 13.1 ccg/ml); and B 
aculeacin A ((0) control, (A) 26 fig/ml, (m) 66 @/ml, (?I 
132 pg/ml). 
I 
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Fig.2. Inhibition of p-(1,3) glucan-synthase by papulacandin 
B in the presence (a) and absence (o) of GTP. Maximal 
activities with and without GTP are 14.3 and 4.7 nmol, 
respectively. 
GTP, a typical activator of yeast glucan synthase 
[ 171, also stimulates the enzyme from G. Zactis. The 
effect of papulacandin B, in terms of percentage inhi- 
bition, was the same either in the absence or in pres- 
ence of GTP (Bg.2). The same result was obtained by 
varying the order of addition of the antibiotic and 
GTP to the reaction mixture. 
4. Discussion 
The fact that the antibiotics inhibit the glucan- 
synthase ‘in vivo’ and that the inhibition is indepen- 
dent of the time of incubation suggests hat aculeacln 
A and papulacandin B need not be metabolized or 
interact in a specific way with membrane nzymes in 
order to be active, as has been hypothesized [4]. On 
the other hand, the presence of the antibiotics in a 
growing culture renders the synthase (as measured 
‘in vitro’) partially inactive. These results might be 
explained by assuming an irreversible attachment of 
the antibiotics to the synthase on the plasma mem- 
brane. A verification of this hypothesis will require 
the availability of radioactively labeled antibiotics. 
The addition of papulacandin B increases the affm- 
ity of the enzyme for the substrate and on the other 
hand the activity cannot be driven to zero even in the 
presence of high amounts of antibiotic. This might 
be the behavior of an enzyme [ 161 ln which the El 
complex has higher affinity for the substrate than the 
enzyme alone, however the EIS complex, although 
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productive, would be processed at a lower rate than 
the ES complex. The situation for aculeacin A is 
more or less similar except that this antibiotic is a 
poorer inhibitor. 
The antibiotics may interfere with intermediate 
steps of p-( 1,3) gl ucan-synthase although no indica- 
tion of the presence of lipid intermediates has been 
detected [8]. 
Papulacandin B does not counteract the stimula- 
tion of glucan-synthase by GTP, an indication that 
GTP and the antibiotic interact with the synthase at 
different sites. A more detailed study of the mecha- 
nism of inhibition must await a better knowledge of 
the system and its regulation [ 171 as well as the solu- 
bilization of the enzyme complex. 
The &$ucan is the main structural component of 
S. cerevisiae cell wall whereas in ascomycetes fungi, 
i.e., G. lactis, not only fl-glucan but chitin are the 
structural components [6]. When the synthesis of 
/3-glucan is inhibited, the yeast cell would lyse, whereas 
in fungi having chitin the situation may be not so 
drastic since chitin could somehow compensate to a 
certain extent the defect in fl-glucan synthesis. That 
might explain why the concentration of papulacandin 
B needed to lyse S. cerevisiae [2,4] is not sufficient 
to lyse G. lads. Surprisingly however, the ‘in vitro’ 
inhibition of glucan-synthase from S. cerevisiae by 
papulacandin B is smaller than that described for 
G. lactis (A. D., unpublished).~The~significance of this 
result is unknown. 
Acknowledgements 
We are indebted to Drs E. Cabib, J. Molano, M. J. 
Mazon and V. Notario for critically reading the 
manuscript. P. P. acknowledges the support from a 
fellowship granted by the Ministerio de Universidades 
e Investigation, Spain. This research was aided by a 
grant from Comisi6n Asesora de Investigacidn Cien- 
tifica. 
References 
[l] Mizuno, K., Yagi, A., Satoi, S., Takada, M., Asano, K. 
and Matsuda, T. (197’7) J. Antibiot. 30, 297-302. 
[ 21 Traxler, P., Gruner, J. and Auden, J. A. L. (1977) J. 
Antibiot. 30, 289 -296. 
[ 31 Mizoguchi, J., Saito, T., Mizuno, K. and Hayano, K. 
(1977) J. Antibiot. 30, 308-313. 
[4] Baguley, B. C., Rommele, G., Gruner, J. and Wehrli, W. 
(1979) Eur. J. Biochem. 97,345-351. 
[S] Hamilton-Miller, J. M. T. (1973) Bacterial. Rev. 37, 
166-196. 
(61 Bartnicki-Garcia, S. (1968) Ann. Rev. Microbial. 22, 
87-108. 
[7] Butler, E. E. and Pettersen, L. J. (1972) Mycologia 64, 
365-374. 
[ 81 Shematek, E. M., Braatz, J. A. and Cabib, E. (1980) J. 
Biol. Chem. 255,888-894. 
[9] Durrin, A. and Cabib, E. (1978) J. Biol. Chem. 253, 
4419-4425. 
[lo] Behrens, N. H. and Cabib, E. (1968) J. Biol. Chem. 243, 
502-509. 
[ 111 Lowry, 0. H., Rosebrough, N. J., Farr, A. L. and 
Randall, R. J. (1951) J. Biol. Chem. 193,265-275. 
[ 121 Sietsma, J. H. and Wouters, J. T. M. (1971) Arch. 
Mikrobiol. 79, 263-273. 
[ 131 Durin, A. (1973) PhD Thesis. University of Salamanca, 
Spain. 
[ 141 Dunin, A., Bowers, B. and Cabib, E. (1975) Proc. Natl. 
Acad. Sci. USA 72,3952-3955. 
[ 151 Nakajima, T. and Ballou, C. E. (1975) Proc. Natl. Acad. 
Sci. USA 72,3912-3916. 
[ 161 Segel, 1. H. (1975) in: Enzyme Kinetics, pp. 161-226, 
Wiley, New York. 
[ 171 Shematek, E. M. and Cabib, E. (1980) J. Biol. Chem. 
255,895-902. 
252 
